Biontech SE
BNTX98.080USD
0.000
Fechamento 09/26, 16:00（ET）Cotações atrasadas em 15 min
23.58BValor de mercado
PerdaP/L TTM
Mais detalhes de Empresa
Informações da empresa
Código da empresaBNTX
Nome da EmpresaBiontech SE
Data de listagemOct 10, 2019
CEOProf. Ugur Sahin, M.D.
Número de funcionários6772
Tipo de títulosDepository Receipt
Fim do ano fiscalOct 10
EndereçoAn der Goldgrube 12
CidadeMAINZ
Bolsa de valoresNASDAQ Global Select Consolidated
PaísGermany
Código postal55131
Telefone4949613190840
Sitehttps://www.biontech.com/
Código da empresaBNTX
Data de listagemOct 10, 2019
CEOProf. Ugur Sahin, M.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Sierk Poetting, Ph.D.
Dr. Sierk Poetting, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
767.54K
+1.69%
Mr. Ryan Richardson
Mr. Ryan Richardson
Chief Strategy Officer, Member of the Management Board
Chief Strategy Officer, Member of the Management Board
26.55K
+80.66%
Dr. Ulrich Wandschneider, Ph.D.
Dr. Ulrich Wandschneider, Ph.D.
Independent Deputy Chairman of the Supervisory Board
Independent Deputy Chairman of the Supervisory Board
1.48K
--
Mr. James Ryan
Mr. James Ryan
Member of the Management Board, Chief Legal Officer
Member of the Management Board, Chief Legal Officer
790.00
--
Prof. Rudolf Staudigl, Ph.D.
Prof. Rudolf Staudigl, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
400.00
--
Prof. Anja Morawietz, Ph.D.
Prof. Anja Morawietz, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
240.00
--
Mr. Ramon Zapata Gomez
Mr. Ramon Zapata Gomez
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Helmut Jeggle
Mr. Helmut Jeggle
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Dr. Oezlem Tuereci, M.D.
Dr. Oezlem Tuereci, M.D.
Chief Medical Office, Member of the Management Board
Chief Medical Office, Member of the Management Board
--
--
Ms. Baroness Nicola Blackwood
Ms. Baroness Nicola Blackwood
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Sierk Poetting, Ph.D.
Dr. Sierk Poetting, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
767.54K
+1.69%
Mr. Ryan Richardson
Mr. Ryan Richardson
Chief Strategy Officer, Member of the Management Board
Chief Strategy Officer, Member of the Management Board
26.55K
+80.66%
Dr. Ulrich Wandschneider, Ph.D.
Dr. Ulrich Wandschneider, Ph.D.
Independent Deputy Chairman of the Supervisory Board
Independent Deputy Chairman of the Supervisory Board
1.48K
--
Mr. James Ryan
Mr. James Ryan
Member of the Management Board, Chief Legal Officer
Member of the Management Board, Chief Legal Officer
790.00
--
Prof. Rudolf Staudigl, Ph.D.
Prof. Rudolf Staudigl, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
400.00
--
Prof. Anja Morawietz, Ph.D.
Prof. Anja Morawietz, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
240.00
--
Detalhamento da receita
Moeda: USDAtualizado em: qua, 12 de mar
Moeda: USDAtualizado em: qua, 12 de mar
FY2019
FY2018
FY2017
Por EmpresaUSD
Nome
Receita
Proporção
Collaboration Revenue
84.43M
77.75%
Revenues from Other Sales Transactions
24.16M
22.25%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Collaboration Revenue
84.43M
77.75%
Revenues from Other Sales Transactions
24.16M
22.25%
Distribuição de ações
Atualizado em: dom, 17 de ago
Atualizado em: dom, 17 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
AT Impf GmbH
42.37%
Medine GmbH
16.69%
Baillie Gifford & Co.
3.34%
Fidelity Management & Research Company LLC
2.90%
Flossbach von Storch AG
1.76%
Outro
32.93%
Investidores
Investidores
Proporção
AT Impf GmbH
42.37%
Medine GmbH
16.69%
Baillie Gifford & Co.
3.34%
Fidelity Management & Research Company LLC
2.90%
Flossbach von Storch AG
1.76%
Outro
32.93%
Tipos de investidores
Investidores
Proporção
Corporation
60.58%
Investment Advisor
16.91%
Investment Advisor/Hedge Fund
3.59%
Individual Investor
2.11%
Research Firm
1.00%
Hedge Fund
0.83%
Sovereign Wealth Fund
0.63%
Bank and Trust
0.22%
Pension Fund
0.19%
Outro
13.94%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
815
205.26M
85.38%
-4.32M
2025Q1
851
205.71M
85.57%
-4.55M
2024Q4
869
205.33M
85.56%
+3.19M
2024Q3
843
197.46M
82.52%
-2.61M
2024Q2
819
194.42M
81.78%
-7.50M
2024Q1
835
193.57M
81.42%
-10.02M
2023Q4
897
193.24M
81.29%
-7.90M
2023Q3
920
192.71M
79.62%
-7.47M
2023Q2
940
195.49M
80.61%
-8.54M
2023Q1
953
197.88M
81.52%
-6.52M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
AT Impf GmbH
101.85M
42.37%
-636.54K
-0.62%
Dec 31, 2024
Medine GmbH
40.13M
16.69%
-304.48K
-0.75%
Mar 31, 2025
Baillie Gifford & Co.
8.16M
3.39%
-60.90K
-0.74%
Mar 31, 2025
Fidelity Management & Research Company LLC
5.95M
2.48%
-495.85K
-7.69%
Mar 31, 2025
Flossbach von Storch AG
4.26M
1.77%
-147.21K
-3.34%
Mar 31, 2025
PRIMECAP Management Company
4.05M
1.68%
-249.39K
-5.81%
Mar 31, 2025
Pfizer Inc
3.66M
1.52%
--
--
Mar 31, 2025
Sahin (Ugur MD)
2.05M
0.85%
-724.50K
-26.11%
Mar 31, 2025
Temasek Holdings Pte. Ltd.
1.81M
0.75%
--
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de set
Atualizado em: sáb, 6 de set
Nome
Proporção
iShares Genomics Immunology and Healthcare ETF
3.71%
Global X Genomics & Biotechnology ETF
3.6%
Langar Global HealthTech ETF
3.46%
First Trust NYSE Arca Biotechnology Index Fund
2.97%
Franklin Genomic Advancements ETF
2.68%
VanEck Biotech ETF
2.65%
WisdomTree BioRevolution Fund
1.8%
Virtus LifeSci Biotech Products ETF
1.74%
iShares Biotechnology ETF
1.44%
ProShares Ultra Nasdaq Biotechnology
1.15%
Ver Mais
iShares Genomics Immunology and Healthcare ETF
Proporção3.71%
Global X Genomics & Biotechnology ETF
Proporção3.6%
Langar Global HealthTech ETF
Proporção3.46%
First Trust NYSE Arca Biotechnology Index Fund
Proporção2.97%
Franklin Genomic Advancements ETF
Proporção2.68%
VanEck Biotech ETF
Proporção2.65%
WisdomTree BioRevolution Fund
Proporção1.8%
Virtus LifeSci Biotech Products ETF
Proporção1.74%
iShares Biotechnology ETF
Proporção1.44%
ProShares Ultra Nasdaq Biotechnology
Proporção1.15%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
